VIENNA, Austria, 29 October 2007 – onepharm, a young Viennese biotech company specialised in the development of antiviral and anti-inflammatory drugs, has just successfully finalised an exclusive strategic cooperation agreement with the Japanese pharmaceutical company Minophagen.
